top of page
Loading...
Virtus Convertible & Income Fund II Common Shares of Beneficial Interest (NY:NCZ)
Price and Volume
Detailed Quote| Volume | 66,980 |
| Open | 14.54 |
| Bid (Size) | 13.79 (1,000) |
| Ask (Size) | 15.43 (700) |
| Prev. Close | 14.49 |
| Today's Range | 14.27 - 14.54 |
| 52wk Range | 12.95 - 16.17 |
| Shares Outstanding | N/A |
| Dividend Yield | 10.02% |
Top News
More News
Performance
More News
Read More
Four Virtus Closed-End Funds Add Portfolio Manager
September 26, 2025
NCV, NCZ Announces Date of Reverse Stock Splits
February 03, 2025
NCV, NCZ Announce Reverse Stock Splits and Monthly Distributions
November 20, 2024
Frequently Asked Questions
Is Virtus Convertible & Income Fund II Common Shares of Beneficial Interest publicly traded?
Yes, Virtus Convertible & Income Fund II Common Shares of Beneficial Interest is publicly traded.
What exchange does Virtus Convertible & Income Fund II Common Shares of Beneficial Interest trade on?
Virtus Convertible & Income Fund II Common Shares of Beneficial Interest trades on the New York Stock Exchange
What is the ticker symbol for Virtus Convertible & Income Fund II Common Shares of Beneficial Interest?
The ticker symbol for Virtus Convertible & Income Fund II Common Shares of Beneficial Interest is NCZ on the New York Stock Exchange
What is the current price of Virtus Convertible & Income Fund II Common Shares of Beneficial Interest?
The current price of Virtus Convertible & Income Fund II Common Shares of Beneficial Interest is 14.37
When was Virtus Convertible & Income Fund II Common Shares of Beneficial Interest last traded?
The last trade of Virtus Convertible & Income Fund II Common Shares of Beneficial Interest was at 09/25/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page